Table 3. Comparative of measurements of quality of life (QLQ BR-23) between groups .
Variables |
Baseline
(mean ±SD) |
After 10 weeks
(mean ±SD) |
P value |
Components of function | |||
Body image | 0.001 | ||
Exercise | 58.64±27.78 | 87.3 ±14.85 | |
Control | 64.10±25.36 | 73.39 ±17.93 | |
Sexual function | 0.008 | ||
Exercise | 88.88 ±28.11 | 80.24 ±31.70 | |
Control | 89.10 ±24.90 | 80.76 ±27.76 | |
Sexual pleasure | 0.030 | ||
Exercise | 83.95 ±35.04 | 76.54 ±36.76 | |
Control | 87.17 ±28.40 | 76.92 ±29.46 | |
Future prospect | 0.001 | ||
Exercise | 62.50 ±27.80 | 56.79 ±28.96 | |
Control | 26.92 ±23.13 | 42.30 ±34.71 | |
Total score of functions | 0.001 | ||
Exercise | 65.50 ±6.46 | 27.16 ±26.61 | |
Control | 71.20 ±4.80 | 78.37 ±10.56 | |
Components of symptoms | |||
Side effect of treatment | 0.001 | ||
Exercise | 41.26 ±20.15 | 17.63 ±13.12 | |
Control | 34.98 ±15.35 | 25.09 ±14.20 | |
Breast symptoms | 0.001 | ||
Exercise | 25.61 ±18.62 | 30.70 ±5.55 | |
Control | 13.80 ±5.40 | 24.67 ±13.43 | |
Arm symptoms | 0.001 | ||
Exercise | 42.38 ±23.47 | 12.12 ±10.69 | |
Control | 23.07 ±21.29 | 25.64 ±17.43 | |
Worry of hair loss | 0.001 | ||
Exercise | 46.91 ±38.40 | 19.07 ±13.58 | |
Control | 41.02 ±35.66 | 51.00 ±17.50 | |
Total score of symptoms | 0.001 | ||
Exercise | 37.69 ±17.21 | 17.21 ±12.75 | |
Control | 26.49 ±12.18 | 24.87 ±10.07 |